【レポートの概要（一部）】
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’S Five Force Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. High Prevalence of Influenza
3.4.1.2. Increase In Government Focus On Immunization Programs
3.4.1.3. Emerging Vaccines
3.4.1.4. Technological Progress In Vaccine Administration
3.4.2. Restraints
3.4.2.1. Longer Timelines And Implementation of Stringent Regulations
3.4.2.2. High Costs Associated With The Development of Vaccines
3.4.3. Opportunity
3.4.3.1. High Growth Prospects In Emerging Markets
Chapter 4: Influenza Vaccine Market, By Vaccine Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Quadrivalent
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast
4.2.3. Market Analysis, By Country
4.3. Trivalent
4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast
4.3.3. Market Analysis, By Country
Chapter 5: Influenza Vaccine Market, By Type
5.1. Overview
5.2. Seasonal Influenza Vaccine
5.3. Pandemic Influenza Vaccine
Chapter 6: Influenza Vaccine Market, By Technology
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Egg-Based
6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country
6.3. Cell Culture
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis, By Country
Chapter 7: Influenza Vaccine Market, By Age Group
7.1. Overview
7.1.1. Market Size And Forecast
7.2. Pediatric
7.2.1. Market Size And Forecast, By Region
7.2.2. Market Analysis, By Country
7.3. Adult
7.3.1. Market Size And Forecast, By Region
7.3.2. Market Analysis, By Country
Chapter 8: Influenza Vaccine Market, By Route of Administration
8.1. Overview
8.1.1. Market Size And Forecast
8.2. Injection
8.2.1. Market Size And Forecast
8.2.2. Market Analysis, By Country
8.3. Nasal Spray
8.3.1. Market Size And Forecast
8.3.2. Market Analysis, By Country
Chapter 9: Global Influenza Vaccine Market, By Region
9.1. Overview
9.1.1. Market Size And Forecast
9.2. North America
9.2.1. Key Market Trends And Opportunities
9.2.2. Market Size And Forecast, By Vaccine Type
9.2.3. Market Size And Forecast, By Technology
9.2.4. Market Size And Forecast, By Age Group
9.2.5. Market Size And Forecast, By Route of Administration
9.2.6. Market Size And Forecast, By Country
9.2.6.1. U.S. Market Size And Forecast, By Vaccine Type
9.2.6.2. U.S. Market Size And Forecast, By Technology
9.2.6.3. U.S. Market Size And Forecast, By Age Group
9.2.6.4. U.S. Market Size And Forecast, By Route of Administration
9.2.6.5. Canada Market Size And Forecast, By Vaccine Type
9.2.6.6. Canada Market Size And Forecast, By Technology
9.2.6.7. Canada Market Size And Forecast, By Age Group
9.2.6.8. Canada Market Size And Forecast, By Route of Administration
9.2.6.9. Mexico Market Size And Forecast, By Vaccine Type
9.2.6.10. Mexico Market Size And Forecast, By Technology
9.2.6.11. Mexico Market Size And Forecast, By Age Group
9.2.6.12. Mexico Market Size And Forecast, By Route of Administration
9.3. Europe
9.3.1. Key Market Trends And Opportunities
9.3.2. Market Size And Forecast, By Vaccine Type
9.3.3. Market Size And Forecast, By Technology
9.3.4. Market Size And Forecast, By Age Group
9.3.5. Market Size And Forecast, By Route of Administration
9.3.6. Market Size And Forecast, By Country
9.3.6.1. Germany Market Size And Forecast, By Vaccine Type
9.3.6.2. Germany Market Size And Forecast, By Technology
9.3.6.3. Germany Market Size And Forecast, By Age Group
9.3.6.4. Germany Market Size And Forecast, By Route of Administration
9.3.6.5. France Market Size And Forecast, By Vaccine Type
9.3.6.6. France Market Size And Forecast, By Technology
9.3.6.7. France Market Size And Forecast, By Age Group
9.3.6.8. France Market Size And Forecast, By Route of Administration
9.3.6.9. Uk Market Size And Forecast, By Vaccine Type
9.3.6.10. Uk Market Size And Forecast, By Technology
9.3.6.11. Uk Market Size And Forecast, By Age Group
9.3.6.12. Uk Market Size And Forecast, By Route of Administration
9.3.6.13. Italy Market Size And Forecast, By Vaccine Type
9.3.6.14. Italy Market Size And Forecast, By Technology
9.3.6.15. Italy Market Size And Forecast, By Age Group
9.3.6.16. Italy Market Size And Forecast, By Route of Administration
9.3.6.17. Spain Market Size And Forecast, By Vaccine Type
9.3.6.18. Spain Market Size And Forecast, By Technology
9.3.6.19. Spain Market Size And Forecast, By Age Group
9.3.6.20. Spain Market Size And Forecast, By Route of Administration
9.3.6.21. Rest of Europe Market Size And Forecast, By Vaccine Type
9.3.6.22. Rest of Europe Market Size And Forecast, By Technology
9.3.6.23. Rest of Europe Market Size And Forecast, By Age Group
9.3.6.24. Rest of Europe Market Size And Forecast, By Route of Administration
9.4. Asia-Pacific
9.4.1. Key Market Trends And Opportunities
9.4.2. Market Size And Forecast, By Vaccine Type
9.4.3. Market Size And Forecast, By Technology
9.4.4. Market Size And Forecast, By Age Group
9.4.5. Market Size And Forecast, By Route of Administration
9.4.6. Market Size And Forecast, By Country
9.4.6.1. Japan Market Size And Forecast, By Vaccine Type
9.4.6.2. Japan Market Size And Forecast, By Technology
9.4.6.3. Japan Market Size And Forecast, By Age Group
9.4.6.4. Japan Market Size And Forecast, By Route of Administration
9.4.6.5. China Market Size And Forecast, By Vaccine Type
9.4.6.6. China Market Size And Forecast, By Technology
9.4.6.7. China Market Size And Forecast, By Age Group
9.4.6.8. China Market Size And Forecast, By Route of Administration
9.4.6.9. India Market Size And Forecast, By Vaccine Type
9.4.6.10. India Market Size And Forecast, By Technology
9.4.6.11. India Market Size And Forecast, By Age Group
9.4.6.12. India Market Size And Forecast, By Route of Administration
9.4.6.13. Australia Market Size And Forecast, By Vaccine Type
9.4.6.14. Australia Market Size And Forecast, By Technology
9.4.6.15. Australia Market Size And Forecast, By Age Group
9.4.6.16. Australia Market Size And Forecast, By Route of Administration
9.4.6.17. South Korea Market Size And Forecast, By Vaccine Type
9.4.6.18. South Korea Market Size And Forecast, By Technology
9.4.6.19. South Korea Market Size And Forecast, By Age Group
9.4.6.20. South Korea Market Size And Forecast, By Route of Administration
9.4.6.21. Rest of Asia-Pacific Market Size And Forecast, By Vaccine Type
9.4.6.22. Rest of Asia-Pacific Market Size And Forecast, By Technology
9.4.6.23. Rest of Asia-Pacific Market Size And Forecast, By Age Group
9.4.6.24. Rest of Asia-Pacific Market Size And Forecast, By Route of Administration
9.5. Lamea
9.5.1. Key Market Trends And Opportunities
9.5.2. Market Size And Forecast, By Vaccine Type
9.5.3. Market Size And Forecast, By Technology
9.5.4. Market Size And Forecast, By Age Group
9.5.5. Market Size And Forecast, By Route of Administration
9.5.6. Market Size And Forecast, By Country
9.5.6.1. Brazil Market Size And Forecast, By Vaccine Type
9.5.6.2. Brazil Market Size And Forecast, By Technology
9.5.6.3. Brazil Market Size And Forecast, By Age Group
9.5.6.4. Brazil Market Size And Forecast, By Route of Administration
9.5.6.5. Saudi Market Size And Forecast, By Vaccine Type
9.5.6.6. Saudi Market Size And Forecast, By Technology
9.5.6.7. Saudi Market Size And Forecast, By Age Group
9.5.6.8. Saudi Market Size And Forecast, By Route of Administration
9.5.6.9. South Africa Market Size And Forecast, By Vaccine Type
9.5.6.10. South Africa Market Size And Forecast, By Technology
9.5.6.11. South Africa Market Size And Forecast, By Age Group
9.5.6.12. South Africa Market Size And Forecast, By Route of Administration
9.5.6.13. Rest of Lamea Market Size And Forecast, By Vaccine Type
9.5.6.14. Rest of Lamea Market Size And Forecast, By Technology
9.5.6.15. Rest of Lamea Market Size And Forecast, By Age Group
9.5.6.16. Rest of Lamea Market Size And Forecast, By Route of Administration
Chapter 10: Company Profiles
10.1. Astrazeneca Plc (Astrazeneca)
10.1.1. Company Overview
10.1.2. Company Snapshot
10.1.3. Operating Business Segments
10.1.4. Product Portfolio
10.1.5. Business Performance
10.2. Biodiem
10.2.1. Company Overview
10.2.2. Company Snapshot
10.2.3. Operating Business Segments
10.2.4. Product Portfolio
10.2.5. Business Performance
10.3. Csl Limited (Seqirus Gmbh)
10.3.1. Company Overview
10.3.2. Company Snapshot
10.3.3. Operating Business Segments
10.3.4. Product Portfolio
10.3.5. Business Performance
10.3.6. Key Strategic Moves And Developments
10.4. Emergent Biosolutions
10.4.1. Company Overview
10.4.2. Company Snapshot
10.4.3. Operating Business Segments
10.4.4. Product Portfolio
10.4.5. Business Performance
10.5. F. Hoffmann-La Roche Ltd.
10.5.1. Company Overview
10.5.2. Company Snapshot
10.5.3. Operating Business Segments
10.5.4. Product Portfolio
10.5.5. Business Performance
10.6. Gamma Vaccines Pty Ltd.
10.6.1. Company Overview
10.6.2. Company Snapshot
10.6.3. Operating Business Segments
10.6.4. Product Portfolio
10.7. Glaxosmithkline Plc
10.7.1. Company Overview
10.7.2. Company Snapshot
10.7.3. Operating Business Segments
10.7.4. Product Portfolio
10.7.5. Business Performance
10.7.6. Key Strategic Moves And Developments
10.8. Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
10.8.1. Company Overview
10.8.2. Company Snapshot
10.8.3. Operating Business Segments
10.8.4. Product Portfolio
10.8.5. Business Performance
10.9. Novartis Ag
10.9.1. Company Overview
10.9.2. Company Snapshot
10.9.3. Operating Business Segments
10.9.4. Product Portfolio
10.9.5. Business Performance
10.10. Pfizer, Inc.
10.10.1. Company Overview
10.10.2. Company Snapshot
10.10.3. Operating Business Segments
10.10.4. Product Portfolio
10.10.5. Business Performance
10.10.6. Key Strategic Moves And Developments
10.11. Sanofi
10.11.1. Company Overview
10.11.2. Company Snapshot
10.11.3. Operating Business Segments
10.11.4. Product Portfolio
10.11.5. Business Performance
10.12. Sinovac Biotech Ltd.
10.12.1. Company Overview
10.12.2. Company Snapshot
10.12.3. Operating Business Segments
10.12.4. Product Portfolio
10.12.5. Business Performance
【レポート販売概要】
■ タイトル：インフルエンザワクチンの世界市場：ワクチンタイプ別（四価、三価）、タイプ別（季節性、パンデミック）、技術別（卵ベース、細胞ベース）、年齢別（小児、成人）、投与経路別（注射、点鼻薬）■ 英文：Influenza Vaccine Market by Vaccine Type (Quadrivalent and Trivalent), Type (Seasonal and Pandemic), Technology (Egg-based and Cell-based), Age Group (Pediatric and Adult), and Route of Administration (Injection and Nasal Spray): Global Opportunity Analysis and Industry Forecast, 2019-2026
■ 発行日：2019年10月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9DC028
■ 調査対象地域：グローバル
- 微生物検査の世界市場2017-2021ABSTRACTAbout Microbiology Testing Microbiological tests are conducted to study the various types of microbes such as bacterial, yeast, fungi, and viruses and their effects on an individual. Microbial testing products provide a wide array of experimental approaches for the diagnosis of infections. Microbiological testing helps detect the presence of pathogenic microorganisms and their metabolites …
- UAV用ソフトウェアの世界市場• Do you need UAV Software market data?• Succinct UAV Software market analysis? • Technological insight? • Clear competitor analysis? • Actionable business recommendations? Read on to discover how this definitive report can transform your own research and save you time. The global UAV Software market consists of worldwide government spending on the procurement, development, and upgrades of UAV sof …
- Market Analysis and Benefit Realization Management (BRM) SolutionsInformation Technology (IT) is a significant component of capital spending for most companies, representing typically 50 % to 75 % of total expenditures. Benefit Realization Management (BRM) is an approach used to identify, prioritize and optimize business benefits arising from IT projects, which cannot be done effectively through traditional financial techniques. It is also known as value managem …
- 中国の住宅ローン市場2016-2020About Housing Mortgage A mortgage is a debt instrument that borrowers can use to secure collateral for any specific real estate property. By taking a loan, the borrower and business firm can execute real estate deal in a single payment. While the lender releases the entire value of the real estate purchase, the borrower repays the loan amount in fixed sets of payment within fixed tenure. If the bo …
- 世界のM2M市場におけるトップ20企業分析2016The latest report from business intelligence provider visiongain offers comprehensive analysis of the global M2M market leaders. Visiongain assesses that the machine to Machine (M2M) market will generate revenues of $26.7 billion in 2016. Now: “China’s IoT Services Revenues to Grow Faster than Any Other Major Country” This is an example of the business critical headline that you need to know about …
- 東南ヨーロッパのLTE市場（LTE in the Southeast Europe: Contracts, Operator Reviews, Spectrum Strategies, Subscriptions, Pricing and Forecasts 2011-2015）The LTE industry is growing at a rapid pace worldwide and by 2015 it is estimated that South Eastern Europe Region will have 6.9 Million subscriptions which will represent 1.7% of the worldwide market share. Future developments of LTE networks will be reliant on spectrum re-farming by regulators and also on finalizing the analogue switchover due to a need for digital dividend frequencies. LTE on s …
- 酪農家畜管理の世界市場予測（～2022年）：搾乳パーラー、メーター、センサー、生殖・健康、畜牛管理、ソフトウェア“The dairy herd management market projected to grow at a CAGR of 6.7%”The global dairy herd management market is projected to reach USD 3.55 billion by 2022 from USD 2.57 billion in 2017, at a CAGR of 6.7%. Factors such as the increasing herd size of dairy farms, growing production and consumption of milk and dairy products globally, rising public-private funding and investments in dairy farming, …
- 人工心臓弁の世界市場分析および予測MediPoint: Prosthetic Heart Valves - Global Analysis and Market Forecasts Summary The global prosthetic heart valves (PHV) market is a dynamic, billion-dollar market that is expected to grow through 2020. Recent advancements in the field of interventional cardiology have greatly improved clinical outcomes for patients. Prosthetic heart valves, including mechanical valves, tissue valves, and transc …
- 水素生成の世界市場予測（～2023年）“Increasing adoption of fuel cell vehicles is expected to drive the overall hydrogen generation market.” The hydrogen generation market is expected to grow from USD 135.5 billion in 2018 to USD 199.1 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 8.0% from 2018 to 2023. The hydrogen generation market is driven by various factors such as the increasing adoption of fuel cell vehicles in …
- 自動車用小型カーナビ（PND）の世界市場2016-2020：工場装着IVS、アフターマーケットIVS、スマートフォン/タブレットベースナビゲーションシステム、PNDAbout Automotive Personal Navigation Systems The automotive industry is seeing structural changes since the past decade in the form of engine downsizing, electrification of automotive mechanism, emission regulations, and enhanced connectivity and safety. Among these innovations, connectivity plays a disruptive role in the traditional automotive value chain with various non-automotive players flood …
- グリセリンの世界市場予測（～2021年）The global market for glycerin is projected to reach USD 3.12 Billion by 2021, at a CAGR of 6.8% during the forecast period. The global glycerin industry is witnessing growth on account of increasing applications, and increasing demand in the Asia-Pacific region, mainly from China, Japan, and India. Also, the growing demand for glycerin in chemical intermediate production is expected to drive mark …
- 世界の電磁鋼市場2015The Global Electrical Steel Industry Report 2015 is a professional and in-depth study on the current state of the Electrical Steel industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Electrical Steel market analysis is provided for the international markets including development trends, competitive la …
- 医療機器リーダーシリーズ：コンパニオン診断薬（CDx）開発、製造および販売のトップ企業2016Companion Diagnostics – Discover Leading Companies’ Activities and Outlooks How are companies in the companion diagnostics (CDx) industry performing? Visiongain’s new report gives you data, analysis and discussions for producers of those medical devices. Our study lets you assess top companies in that industry and market, showing you their activities and outlooks. There you see financial results, …
- 世界の小型自動車用電子制御ブレーキング市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE electronic braking sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE electronic braking market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategi …
- 内分泌機能検査の世界市場2015During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more …
